Zydus Wellness Ltd Upgraded to Hold by MarketsMOJO on Strengthened Financials and Valuation

Financial Performance Drives Upgrade

The primary catalyst for the upgrade is the marked improvement in Zydus Wellness’s financial trend. The company’s financial grade has shifted from flat to positive, supported by robust quarterly results for June 2026. Profit before tax excluding other income (PBT LESS OI) surged to ₹158.30 crores, representing a remarkable 139.0% growth compared to the previous four-quarter average. Similarly, net profit after tax (PAT) rose by 99.8% to ₹118.90 crores, while net sales expanded by 45.1% to ₹1,437.00 crores over the same period.

These figures underscore a strong operational recovery and enhanced profitability, which have been pivotal in improving the company’s financial score from 3 to 12 in the last three months. However, some caution remains due to a sharp increase in interest expenses, which grew by 374.11% to ₹106.20 crores over nine months, and a relatively elevated debt-to-equity ratio of 0.55 times at half-year, the highest recorded for the company. Despite these concerns, Zydus Wellness maintains a manageable debt servicing capacity, reflected in a Debt to EBITDA ratio of 6.28 times.

Valuation Metrics Turn Attractive

Alongside financial improvements, the company’s valuation grade has been upgraded from fair to attractive. Zydus Wellness currently trades at a price-to-earnings (PE) ratio of 73.8, which, while high, is considered reasonable within the context of its growth prospects and sector peers. The price-to-book value stands at 2.9, and enterprise value to EBIT and EBITDA ratios are 49.62 and 33.55 respectively, indicating a premium valuation but one that is justified by recent earnings momentum.

Notably, the enterprise value to capital employed ratio is a modest 2.24, and the return on capital employed (ROCE) is 4.07%, signalling efficient utilisation of capital. The return on equity (ROE) is similarly modest at 4.09%. Dividend yield remains low at 0.23%, consistent with the company’s reinvestment strategy. Compared to peers such as Gillette India and Hatsun Agro, which are rated expensive, Zydus Wellness’s valuation is deemed attractive, especially given its recent financial turnaround.

Technical Indicators Signal Mildly Bullish Outlook

The technical grade for Zydus Wellness has shifted from bullish to mildly bullish, reflecting a nuanced market sentiment. Weekly and monthly MACD indicators remain bullish, supported by a bullish KST (Know Sure Thing) on both timeframes. Bollinger Bands and daily moving averages also suggest mild bullishness, indicating potential for upward price movement.

However, some mixed signals persist. The weekly Dow Theory indicator is mildly bearish, and the On-Balance Volume (OBV) shows a mildly bearish trend on the weekly chart with no clear trend monthly. The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no definitive signal. This combination suggests cautious optimism among traders, with the stock price fluctuating between ₹525.90 and ₹598.80 on the day of analysis.

Quality Assessment and Market Position

Zydus Wellness holds a Mojo Score of 64.0 and a Mojo Grade of Hold, upgraded from a previous Sell rating as of 5 August 2026. The company is classified as a small-cap within the FMCG sector, which is known for steady demand but also intense competition. Institutional holdings stand at a healthy 22.45%, indicating confidence from sophisticated investors who typically conduct thorough fundamental analysis.

Despite recent price declines—down 3.28% on the day and negative returns over the past week (-8.37%) and month (-11.22%)—the stock has outperformed the Sensex over longer periods. Year-to-date returns are positive at 16.37%, and the stock has delivered 33.92% returns over the last year, significantly outperforming the Sensex’s -2.64% over the same timeframe. Over three and ten years, the stock has generated returns of 85.51% and 229.66% respectively, well ahead of the benchmark indices.

Long-Term Growth and Challenges

While recent quarters have shown strong growth, the company’s long-term operating profit growth remains modest, with a compound annual growth rate of just 3.56% over the past five years. This slower growth rate tempers enthusiasm somewhat, especially given the high valuation multiples. Additionally, profits have declined by 28.9% over the past year despite the stock’s price appreciation, highlighting some volatility in earnings quality.

Nevertheless, the company’s ability to service debt remains strong, and its valuation discount relative to peers suggests potential upside if earnings momentum continues. Investors should weigh these factors carefully, considering both the improved fundamentals and the risks posed by rising interest costs and moderate long-term growth.

Conclusion: A Balanced Hold Recommendation

Zydus Wellness Ltd’s upgrade to a Hold rating reflects a balanced view of its current position. The company’s recent financial performance has improved markedly, with strong quarterly growth in sales and profits driving a positive financial trend. Valuation metrics have become more attractive relative to peers, and technical indicators suggest a cautiously optimistic outlook.

However, investors should remain mindful of the company’s elevated interest expenses, moderate long-term growth, and recent price volatility. The stock’s strong institutional backing and market-beating returns over multiple time horizons provide additional confidence, but the Hold rating signals that further confirmation of sustained growth and earnings stability is needed before a more bullish stance can be adopted.

For investors seeking exposure to the FMCG sector with a focus on improving fundamentals and attractive valuation, Zydus Wellness presents a compelling case for consideration within a diversified portfolio.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →